Related Experiment Video
Updated: Mar 17, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Novel de novo EEF1A2 missense mutations causing epilepsy and intellectual disability
Wayne W K Lam1, John J Millichap2, Dinesh C Soares3
1South East of Scotland Clinical Genetics ServiceCrewe RoadEdinburghUK; Centre for Genomic & Experimental MedicineMRC Institute of Genetics and Molecular MedicineUniversity of EdinburghWestern General HospitalCrewe RoadEdinburghEH4 2XUUK; Muir Maxwell Epilepsy CentreUniversity of Edinburgh20 Sylvan PlaceEdinburghEH9 1UWUK; Paediatric NeurosciencesRoyal Hospital for Sick ChildrenSciennes RoadEdinburghEH9 1LFUK.
Mutations in the EEF1A2 gene are linked to epilepsy and intellectual disability, with new cases showing a wider severity range and distinct facial features. This gene is crucial for neurological development.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Exome sequencing identifies novel epilepsy genes, including EEF1A2.
- EEF1A2 mutations were previously found in severe epilepsy cases.
- This study investigates additional cases with EEF1A2 mutations.
Purpose of the Study:
- To identify and characterize new mutations in the EEF1A2 gene.
- To explore the phenotypic spectrum associated with EEF1A2 mutations.
- To determine the clinical significance of EEF1A2 in epilepsy and intellectual disability.
Main Methods:
- Case identification through the Deciphering Developmental Disabilities project and other clinical/online resources.
- Exome sequencing of affected individuals.
- Clinical evaluation and phenotypic analysis of new cases.
Main Results:
- Seven new cases with distinct EEF1A2 mutations were identified.
- Mutations cause epilepsy and intellectual disability across a broad severity spectrum.
- Shared subtle facial dysmorphic features were observed in new cases.
- Mutations affect highly conserved amino acid positions, suggesting functional importance.
Conclusions:
- EEF1A2 is implicated in epileptic encephalopathy and less severe epilepsy with intellectual disability.
- A recognizable phenotype, including specific facial features, may aid in identifying EEF1A2 mutation carriers.
- EEF1A2 should be considered in the genetic workup of epilepsy and intellectual disability.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: